Comparison of the biodistribution and the efficacy of monoclonal antibody labeled with either 131I or 186Re in human ovarian cancer xenografts
- 1 July 1997
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 38 (4) , 813-823
- https://doi.org/10.1016/s0360-3016(97)00007-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparison of the monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenograftsBritish Journal of Cancer, 1996
- Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancerEuropean Journal Of Cancer, 1995
- Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.The Journal of cell biology, 1994
- Radioimmunotherapy: no news from the newcomerZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Technetium-99m, rhenium-186, and rhenium-188 direct-labeled antibodiesCancer, 1994
- Adjuvant therapy of ovarian cancer with radioactive monoclonal antibodyBritish Journal of Cancer, 1993
- 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizesBritish Journal of Cancer, 1992
- Comparisons of the efficacy of 186Re- and 131I-labeled antibody in multicell spheroidsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- WiDr is a derivative of another colon adenocarcinoma cell line, HT-29Cancer Genetics and Cytogenetics, 1987
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984